(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol

Star0

DB08321ExperimentalSmall molecule

(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol: Overview.

Mechanism: Pharmacologically active on Lysosomal acid glucosylceramidase
Curator reviewed
Formula / weight: C₁₅H₂₉NO₄ · 287.3951 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL1234952PubChem9817381

Structure

InChIKeyUPZUHYMBTUUPML-KBXIAJHMSA-NSMILES[H][C@@]1(O)C(CO)=C[C@@]([H])(NCCCCCCCC)[C@]([H])(O)[C@@]1([H])O

Targets

P04062GBA1Q16706MAN2A1

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with (1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account